GGrantIndex
Sort

50,496 grants matching lung cancer

A novel flat-panel detector for advanced on-board radiation therapy imaging

$609,121
Ross I. Berbeco · Dana-Farber Cancer Inst · R01 · FY2020 · CA

Role of Selenium in Cancer and Health

$609,110
Dolph Hatfield · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Modeling bi-directional signaling and cytoskeletal dynamics in 3D cell migrations

$609,098
Muhammad Hamid Zaman · Boston University (Charles River Campus) · U01 · FY2015 · CA

RESEARCH ADMINISTRATION

$609,088
Henry Lewis · Florida Agricultural And Mechanical Univ · G12 · FY2010 · RR

Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy

$609,073
Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

$609,048
Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

Mechanics of Monolayer Migration

$609,023
Jeffrey J Fredberg · Harvard School Of Public Health · R01 · FY2015 · HL

Role of mouse microbiome in cancer and inflammation

$608,998
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Predictors of CVD among breast cancer survivors in an integrated health system

$608,974
Marilyn L Kwan · Kaiser Foundation Research Institute · R01 · FY2019 · CA

New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells

$608,954
Traci Leigh Hilton · Ubivac, Llc · R44 · FY2013 · CA

Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung SABR

$608,909
Amit Sawant · University Of Maryland Baltimore · R01 · FY2016 · CA

A Randomized Trial of Incentives for Research Participation

$608,854
Scott D Halpern · University Of Pennsylvania · R01 · FY2018 · CA

A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC

$608,827
Patricia Jean Hollen · University Of Virginia · R01 · FY2013 · CA

Expanding the Utility of Severe Combined Immuno-Deficient (SCID) Pig Models

$608,822
Christopher Tuggle · Iowa State University · R24 · FY2017 · OD

Integrated, Individualized, Intelligent Prescribing (I3P)

$608,822
Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2018 · HG

Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent

$608,794
Seth J Field · Case Western Reserve University · R01 · FY2023 · CA

Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy

$608,786
Dejana K Braithwaite · University Of Florida · R01 · FY2024 · CA

Photodynamic Therapy of Disseminated Peritoneal Tumor Using New Photosensitizers

$608,725
J Tim Wharton · Lynntech, Inc. · R44 · FY2008 · CA

Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism

$608,669
Nicholas C Denko · Ohio State University · R01 · FY2024 · CA

Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial

$608,663
Pradeep Natarajan · Massachusetts General Hospital · R01 · FY2021 · HL

Natural Products with Selective Cytoxicity to Non Small Cell Lung Cancer

$608,607
John D Minna · Ut Southwestern Medical Center · R01 · FY2020 · CA

Natural Products with Selective Cytoxicity to Non Small Cell Lung Cancer

$608,607
John D Minna · Ut Southwestern Medical Center · R01 · FY2021 · CA

Planning and Evaluation Core

$608,502
Jaime L Matta · Ponce School Of Medicine · U54 · FY2020 · CA

Mitochondrial Metabolism and Cancer

$608,491
Navdeep S. Chandel · Northwestern University At Chicago · R01 · FY2024 · CA

Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC) on Immunotherapy

$608,465
Despina Kontos · University Of Pennsylvania · R01 · FY2021 · CA